Volume : 10, Issue : 04, April – 2023

Title:

31.ASSESSMENT OF PRESCRIBING PATTERN OF BRONCHODILATORS AND CORTICOSTEROIDS IN THE MANAGEMENT OF COPD
‬

Authors :

Hephziba*, Simchu, Thomas.R Prasobh.G.R, E.Sam Jeevakumar, Anjana. U. J

Abstract :

Introduction: Chronic obstructive pulmonary disease (COPD) is a disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases.
Objectives: The objective of this study is to assess the prescribing pattern of bronchodilators and corticosteroids on the management of COPD.
Conclusion: COPD will remain a significant healthcare problem for years to come. Early identification of the disease through primary care screening for the common symptoms in smokers or those exposed to air pollutants or toxins will lead to earlier diagnosis and treatment. Focusing on smoking cessation will have a great impact on the progression of disease. Advancements in treatment will require translation of a more fundamental understanding of the pathophysiologic pathways involved into disease-modifying interventions. At present, management efforts are directed toward improving patients’ symptoms and functional limitations through carefully selected treatment modalities.
Keywords: Chronic obstructive pulmonary disease, Bronchodilators, Corticosteroids, Global Initiative for Chronic Obstructive Lung Disease, Forced expiratory volume in 1 second, Forced vital capacity, pulmonary function test.

Cite This Article:

Please cite this article in press Hephziba et al, Assessment Of Prescribing Pattern Of Bronchodilators And Corticosteroids In The Management Of COPD., Indo Am. J. P. Sci, 2023; 10 (04).

Number of Downloads : 10

References:

1. David Price, Daniel West, Katsiaryma Bichel. An analysis of real-life prescribing patterns in the management of chronic obstructive pulmonary disease in UK primary-care setting.
2. Sarah E Petite. Characterization of chronic obstructive pulmonary disease prescribing patterns in the United States. Pulmonary Pharmacology and Therapeutics; 2018, pg. no: 49,119-122.
3. Mirko Di Martino, Nera Agabiti, Lisa Bauleo, Ursula Kirchmaver, Silvia Cascini Riccardo Pistelli, Vittoria Colamesta, Elisabetta Patorno. Use patterns of long-acting bronchodilators in routine COPD Care: the OUTPUL study. Journal of Chronic Obstructive Pulmonary Disease; 2014, pg. no: 11(4), 414-423.
4. Zainabath Sazmi, Sanjiv Karale, Sharanya S Rao, Amrutha Sathyan .Assessment of prescribing pattern of COPD patients. Indian Journal of Pharmacy Practice; 2022, pg. no: 15(3).
5. Morven Wilkie, Simon Finch, Stuart Schembri. Inhaled corticosteroids for chronic obstructive pulmonary disease- the shifting treatment paradigm. Journal of Chronic Obstructive Pulmonary Disease; 2015, pg.no: 12(5), 582-590.
6. Rachael L Di Santostefano, Tim Sampson, Hoa Van Le .Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in COPD: A New-User-Cohort Study. PloS one; 2014, pg.no: 9(5), e 97149.
7. Alejandro Casas, Maria Montes De Oca, Ana MB Menezes, Fernado C Wehrmeister. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study. International journal of chronic obstructive pulmonary disease; 2018, pg.no:13, 1545.
8. Maria Montes de Oca, Maria Victorina Lopez Varela, Jose Jardim Roberto Stirvulov, Filip Surmont. Bronchodilator treatment for COPD in primary care of four Latin American countries: The multinational, cross-sectional, non- interventional PUMA. Pulmonary Pharmacology and Therapeutics; 2016, pg.no: 38, 10-16.
9. Jose Luis Lopez-Campos, Bernardino Alcazas Navarrete, Myriam Calle Rubio. Determinants of medical; prescriptions for COPD care: an analysis of the EPOCONSUL. International Journal of Chronic Obstructive Pulmonary Disease; 2018, pg.no: 13, 2279.
10. GUY Brusselle, David Price, Kevin Gruffy dd Jones, Marc Miravitlles, Dorothy L Keininger. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. International Journal of Chronic Obstructive Pulmonary Disease; 2015, pg.no: 10, 2207.
11. Essentials of Medical Physiology by K Sembulingam, Prema Sembulingam; 6th edition; pg.no:690-699.
12. Clinical Pharmacy and Therapeutics by Roger Walker, Cate Whittlesea; 5th edition; pg.no: 431-432.
13. Clinical drug therapy rationales for nursing practice by Anne Collins Abrams; 5th edition; pg. no: 618.
14. Applied Therapeutics, the clinical use of drugs by Mary Anne, Koda-Kimble, Lloyd Yee Young; 7th edition; chapter: 22.
15. Tricia Kinman, Erika Klein, Alan Carter. COPD drugs: A list of medications to help relieve the symptoms; Updated on December 7, 2020.
16. Clinical Pharmacy and Therapeutics by Eric. T. Herfindal; 4th edition; pg.no: 374-380.
17. Essentials of Medical Pharmacology by K. D. Tripathi; 8th edition; chapter 12; pg.no: 242.
18. Principles of Pharmacology by H L Sharma, K K Sharma; published by Paras Medical Publisher; 2nd edition; chapter 49; pg.no: 653.